• Users Online: 148
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2014  |  Volume : 2  |  Issue : 4  |  Page : 205-216

Progressive macular hypomelanosis pathogenesis and treatment: a randomized clinical trial


1 Microbiology & Immunology Department, Faculty of Medicine, Tanta University, Egypt
2 Dermatology & Venereology Department, Faculty of Medicine, Tanta University, Egypt
3 Histology Department, Faculty of Medicine, Tanta University, Egypt
4 Dermatology Department, El-Dammam Hospital, Saudi Arabia

Correspondence Address:
Azza M Hassan
Microbiology & Immunology Department, Faculty of Medicine, Tanta University
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.jmau.2014.09.001

Rights and Permissions

Background: Progressive macular hypomelanosis (PMH) is a cosmetically disturbing skin disorder that is poorly understood with indefinite treatment. The aim of the present study was to clinically outline PMH and study its pathogenesis. Based upon the literature suggesting improvement of PMH with antibiotic therapy to decrease Propionibacterium acnes (P. acnes) colonization, different treatment modalities were tried to reach the best treatment option. Patients and methods: This study included 12 newly diagnosed PMH selected patients who attended Tanta University Hospital outpatient clinic of Dermatology and Venereology from June 2009 to March 2010. Patient’s lesions were subjected to wood’s lamp and potassium hydroxide (KOH) examination as well as biopsies used in histological, immunohistochemical, bacteriological and electron microscopic examination. A randomized clinical trial with different treatment modalities was applied. Results: The patient’s mean age was 25 ±10.8 with significant female predominance (P=0.0001). Reduction of epidermal melanosomes and tyrosine activity together with difference in distribution of S100 proteins in hypopigmented skin was demonstrated. Abnormal distribution of tonofilaments was noticed inside keratinocytes with increased apoptosis. P. acnes were detected in hair follicles of 83.3% hypopigmented lesions. Administration of local and systemic antimicrobial treatment with narrow band ultraviolet B (NBUVB) phototherapy for 3 months was the best treatment modalities. Conclusion: The etiology of PMH is multifactorial where genetic predisposition, the presence of P. acnes and hormonal imbalance play the main role. Administration of local and systemic antimicrobial treatment with NBUVB phototherapy for 3 months is an effective treatment regimen for PMH.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3351    
    Printed190    
    Emailed0    
    PDF Downloaded138    
    Comments [Add]    
    Cited by others 2    

Recommend this journal